Biotech News - Serono S.A. (ADR) (Public, NYSE:SRA)

Serono S.A. (ADR) (Public, NYSE:SRA)

Germany's Merck gets US antitrust nod for Serono

WASHINGTON, Oct 31 (Reuters) - U.S. antitrust authorities have
approved German drugmaker Merck KGaA's (MRCG.DE: Quote, Profile,
Research) takeover of biotech firm Serono SA (SEO.VX: Quote,
Profile, Research), the U.S. Federal Trade Commission said in a
notice on Tuesday.

U.S. officials closed their review of the transaction without taking
any action to block it, the agency said.

More here:
http://today.reuters.com/news/articleinvesting.aspx?view=CN&storyID=2006-10-31T163849Z_01_N31198577_RTRIDST_0_HEALTH-SERONO-ANTITRUST.XML&rpc=66&type=qcna

Serono posts near 20 pct increase in third quarter net profit

The Swiss biotechnology and pharmaceuticals company Serono reported
third quarter net income of 170.6 million dollars (136.1 million
euros) for the third quarter, a 19.8 percent increase over the same
period last year.

Total revenue in the third quarter rose 9.5 percent over the same
period last year to 699.1 million dollars, the company said in a
statement.

Sales of Serono's flagship multiple sclerosis drug Rebif totalling
374.8 million dollars accounted for more than half of the Swiss
company's revenues.

http://tech.groups.yahoo.com/group/biotech-news/
http://www.arizonabiotech.com/
http://famouspeople.wordpress.com/

http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/
http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/

Yahoo! Groups Links

<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/biotech-news/

<*> Your email settings:
Individual Email | Traditional

<*> To change settings online go to:
http://groups.yahoo.com/group/biotech-news/join
(Yahoo! ID required)

<*> To change settings via email:
mailto:biotech-news-digest@yahoogroups.com
mailto:biotech-news-fullfeatured@yahoogroups.com

<*> To unsubscribe from this group, send an email to:
biotech-news-unsubscribe@yahoogroups.com

<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/